251 - Evaluation of Diapered Area Skin Characteristics from Babies with Neonatal Opioid Withdrawal Syndrome (NOWS)

Andrew N. Carr, Procter & Gamble, Cincinnati, OH, United States; Gina M. Fadayel, Procter & Gamble, Cincinnati, OH, United States; Lisa C. Bohman, Procter & Gamble, Cincinnati, OH, United States; Lijuan Li, The Procter and Gamble Company, Mason, OH, United States; Jennifer I. Byrd, P&G, Cincinnati, OH, United States; Marcia Kneusel, University of South Florida, Tampa, FL, United States; Tanner Wright, USF Health Morsani College of Medicine, Tampa, FL, United States